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ABSTRACT
Mycobacterium tuberculosis (Mtb) targets alveolar macrophages and has a high
tolerance to the macrophage’s antimicrobial effectors, such as low pH, reactive oxygen
species, and reactive nitrogen species. It has been reported and widely accepted that
Mtb disarms macrophages through arresting the normal maturation process of the
phagosomes. Inhibition of phagosome-lysosome fusion and phagosome acidification is
an effective survival strategy at the early stage of infection. This behavior allows Mtb to
remain and replicate within the phagosomes of macrophages. At the later stage of
infection, the pathogen translocates from the phagolysosomal compartments into the
cytosol of host cells by phagolysosomal rupture. The main protein involved in virulence
is known as MtbESAT-6, which is secreted by the ESX-1 secretion system and
reportedly shows membrane-lysing properties. The ESX-1 secreting system is essential
for the toxicity of MTB. The membrane interacting activity of MtbESAT-6 plays an
important role during the infection. In this study, N- and C-terminal truncations and
Cysteine mutations on the protein were generated to determine the role of N- and Cterminal flexible loops of MtbESAT-6 in membrane-interaction and the key membraneinteracting residues of MtbESAT-6. A series of fluorescence assays, including ANS,
ANTS/DPX and Tryptophan, have demonstrated that both N- and C- terminal flexible
loops were crucial for the membrane-interacting activity, suggesting a model that the
loop area of the protein initiate the membrane attachment and the central helix-turnhelix inserts into the membranes. The study of ESX-1 secreting system, especially the
molecular mechanism of MtbESAT-6 membrane interaction, is essential for us to
understand how this virulence factor contributes to bacterial infection, and eventually
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will facilitate development of novel therapeutics against tuberculosis.
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CHAPTER 1: INTRODUCTION
1.1

MYCOBACTERIUM TUBERCULOSIS AND THE DISEASE

Mycobacterium tuberculosis (Mtb) is an aerobic, non-motile bacillus, which grows within
cells of a host organism, and can be cultured in the laboratory setting. The bacteria
divides every 16 to 20 hours and has a well-developed unique cell wall that contains a
considerable amount of many fatty acids including mycolic acid, providing an
extraordinary lipid barrier giving it the unique property of acid-fast staining for
identification. This unique barrier is responsible for many of the medically challenging
physiological characteristics of Mtb, including resistance to antibiotics and host defense
mechanisms. Mtb infection begins when the mycobacteria reach the pulmonary alveoli,
where they invade and replicate within endosomes of alveolar macrophages.
Reportedly, approximate 10% lifetime chance that the latent infection will progress to
active tuberculosis disease. Tuberculosis of the lungs may also occur via infection from
the blood stream. This hematogenous transmission can also spread infection to more
distant sites, such as peripheral lymph nodes, the kidneys, the brain, and the bones.
According to the 2011 annual report by the World Health Organization (WHO) [1, 2], 8.7
million people fell ill with tuberculosis (TB) and 1.4 million died. In the same year, a total
of 10,521 new TB cases were reported in the United States, an incidence of 3.4 cases
per 100,000 population, which is 6.4% lower than the rate in 2010 (Fig. 1.1).
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Figure

1.1:

WHO

report

of

tuberculosis

cases

during

2011

worldwide.

(http://www.whadvocacy.com/node/255,WHO)
1.2

BCG

The bacilli Calmette-Guerin (BCG) vaccine, discovered in 1921 by Albert Calmette and
Camille Guerin, is used to prevent tuberculosis with an efficacy of 80% [3]. BCG is a live
avirulent bovine tuberculosis bacillus (Mycobacterium bovis). Because the living bacilli
evolve to make the best use of the available nutrients, they become more adapted to
their traditional environment, human blood, and no longer induce the disease when
introduced into a human host for their preservation. Immunogenic activity however is
still retained due to their wild type ancestry similarity.
This attenuated strain failed to escape from the macrophage due to the lack of a 6kD
early secretory antigenic target protein (ESAT-6, EsxA, or Rv3875) and its 10kD culture
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filtrate protein partner (CFP-10, EsxB, or Rv3874) due to the deletion of the region of
difference 1 (RD1) [4].
1.3

RD1

RD1 is considered to be the primary attenuating deletion in the related BCG vaccine
strain (Fig. 1.2). The genes of the RD1 region encode a secretory apparatus, termed
ESX-1, which is responsible for exporting CFP-10 and ESAT-6, as a heterodimer [5]. It
has been reported that the products of Rv3870 and Rv3871 may work together to form
a membrane-bound ATPase [6]. The function of two super families of repetitive proteins
Rv3872 (PE) and Rv3873 (PPE) are still unknown. Rv3876 encodes a protein with a
proline-rich N-terminal region and homology in its C-terminal portion to a Pseudomonas
aeruginosa protein involved in flagellar biosynthesis, including a deviant Walker A [6].
Rv3877 is an integral membrane protein of unknown function. The last ORFs in RD1
(Rv3878 and 3879c) are reported not essential for Mtb virulence as they are interrupted
in at least one virulent clinical Mtb [6].
ESAT-6 and CFP-10 have become of great interest in recent years due to their
membrane interacting activity. However, the mechanism is not well understood.
Evidences are needed to confirm all reported functions of ESAT-6 and CPF-10.

Figure 1.2: The genes in RD1 region of Mtb. [7]
3

1.4

ESAT-6/CFP-10

The esx-1 locus comprises of 11 genes that encode the ESX-1 secretion system and
two secreted proteins: MtbESAT-6 and MtbCFP-10. ESAT-6 and CFP-10 are secreted
in pair by ESX-1. Biochemical analysis has shown that MtbESAT-6 and MtbCFP-10
form a 1:1 heterodimeric complex [8, 9, 10] (Fig. 1.3).

Figure 1.3: ESAT-6/CFP-10 heterodimer. [11]
1.5

SURVIVAL OF MTB IN PHAGOSOME

Mtb, but not BCG, has diverse strategies for evading host immune system. Normally, after bacteria are engulfed into phagosomes by macrophage, phagosomes fuse with
lysosomes and mature into the phagolysosomes. Phagolysosome undergoes an
acidification, and bacteria are killed at this stage by the acidic condition and the
hydrolases inside of the phagolysosome [9, 11]. BCG undergoes the same process as
described above, but for Mtb, at the latent phase, it prevents fusion of phagosomes and
lysosomes. Inhibition of phagosome-lysosome fusion is attributed to limited entrance of
4

lysosomal hydrolases to Mtb and inhibited acidification of phagosomes [12, 13] At the
reactivation phase of Mtb infection, the phagosome-lysosome fusion occurs and
MtbESAT-6 and MtbCFP-10 disrupt the membrane and translocates to the cytosol (Fig.
1.4) [14, 15].

B

Figure 1.4: A. A schematic diagram of Mtb infection and clearance via the autophagic
pathway. [16]
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1.6

FUNCTION OF MTBESAT-6

MtbESAT-6 has been documented to have three important functions in virulence. It
blocks maturation of phagosome where the bacteria are located. It also aids in
prevention of fusion of the phagosome to lysosome so that the digestive enzymes in the
lysosome can’t damage the bacteria. It has also been widely documented that
MtbESAT-6 allows bacteria to escape into the cytosol for replication [17, 18]. However,
the specific mechanisms are still unknown. More evidence is needed to gain insight into
the roles of MtbESAT-6 in Mtb pathogenesis [19, 20, 21].
1.7

SPECIFIC AIMS

Specific Aim 1:
Hypothesis: ESAT-6 proteins from Mtb and from Mycobacterium smegmatis, a nonpathogenic mycobacterium, have different membrane-interacting activities.
Aim: Express and purify ESAT-6 and CFP-10 from Mycobacterium smegmatis, which is
a collaborative project comparing membrane interaction of MtbESAT-6 and MsESAT-6
Specific Aim 2:
Hypothesis: The N- and C-terminal flexible loops of ESAT-6 initiate the membrane
attachment in membrane interaction.
Aim: Determine the role of N- and C-terminal flexible loops of ESAT-6 in membrane
interaction using N- and/or C-terminal truncation mutants.
Specific Aim 3:

6

Hypothesis: The helix structures of ESAT-6 protein insert into the lipid membrane to
form a pore.
Aim: Map the membrane-insertion residues of ESAT-6 using NBD fluorescence
Specific Aim 4:
Hypothesis: The ESAT-6 pores on the membranes have a discrete size.
Aim: Determine the size of ESAT-6 pores using PEGs with different molecular weights.

7

CHAPTER 2: MATERIALS AND METHODS
2.1

EXPRESSION AND PURIFICATION OF MSCFP-10 AND MSESAT-6

MsESAT-6 gene was amplified by PCR and cloned onto the vector pET22b between
Nde I and Xho I restriction sites to produce a C-terminally His-tagged protein. MsCFP10 gene was amplified by PCR and cloned into the vector pGEX4T BamH I/EcoR I sites
to produce a N-terminally GST-tagged protein. The constructs pET22b-MsESAT-6 and
pGEX4T-MsCFP-10 were transformed into Escherichia coli BL21 (DE3) cells, and grew
overnight on LB plate, and the cells were grown at 37°C in 1 liter of LB medium
containing 100 μg/ml carbenicillin in the incubator. 1 mM of IPTG (final concentration)
was added to induce protein expression at OD600 = 0.6-1.0. Induction lasted 3 hours at
37°C for pET22b-MsESAT-6, and 6 hours at 30°C for pGEX4T-MsCFP-10. The cells
were harvested by centrifugation (11,000 rpm, 15 min). Then the cells expressing
MsESAT-6 protein (Insoluble, use on-column refolding) were lysed by sonication in the
wash buffer (50 mM TrisHCl, 10 mM EDTA, 0.5% Triton X-100, pH 8.0). Inclusion
bodies were collected by centrifuging at 15,000 rpm for 15 min at 4 °C. The resulting
pellet (inclusion bodies containing ESAT-6 proteins) was washed three times with the
wash buffer. The pellet was suspended and incubated in the denaturing buffer (8 M
urea, 1 mM EDTA and 100 μM PMSF, pH 7.4) for 3 h at room temperature, followed by
centrifugation at 17,000 rpm for 1 h at 10 °C. At the same time, Ni2+ -charged sepharose
column was equilibrated with the equilibration buffer (20 mM Tris-Cl, 8 M urea, and 20%
glycerol, pH 7.4). The supernatant was loaded onto the equilibrated column after
centrifugation. Additional 300 ml of equilibration buffer was run through the column in
order to wash off unbound proteins. The bound proteins were refolded on the column by
8

gradually removing urea with a 0-88% linear gradient of refolding buffer (20 mM Tris-Cl,
500 mM NaCl, 20% glycerol, pH 7.4) on an ÄKTA FPLC (GE Healthcare) at a flow rate
of 0.5 ml/min overnight. The refolded proteins were then eluted from the column with a
0-100% linear gradient of the elution buffer (20 mM Tris-Cl, 500 mM NaCl, 20%
glycerol, 250 mM imidazole, pH 7.4) at a flow rate 4 ml/min. The fractions then were
collected from the FPLC, followed by SDS-PAGE to identify the proteins. All the
fractions containing the target proteins were pooled, concentrated and applied to gel
filtration chromatography using a Superdex-75 column in the buffer (20 mM TrisHCl,
100 mM NaCl, pH 7.4). Finally, the purity of the proteins was examined in SDS-PAGE
and the proteins were stored at -80°C in small aliquots [22].
For GST-MsCFP-10 protein (soluble, purify from the supernatant), cells were resuspended by Buffer A (PBS, pH 7.3) containing lysozyme with gentle stirring at 4°C for
30 min. Subsequently, the cells were lysed by sonication in the buffer A.

The

supernatant was obtained by centrifuging the lysate at 15,000 rpm for 1 hour at 4 °C.
The supernatant was loaded onto the pre-equilibrated glutathione Sepharose 4B
column (GS4B). The unbound proteins were washed off the column with 300 ml of
buffer A. The bound proteins were eluted with a 0-100% linear gradient of Buffer B (50
mM TrisHCl, 10 mM reduced glutathione, pH 8.0) on an ÄKTA FPLC (GE Healthcare) at
a flow rate of 5 ml/min. The eluted fractions were collected and examined by SDSPAGE to identify the proteins. The fractions containing GST-MsCFP-10 were pooled.
For thrombin digestion, the purified GST-CFP-10 proteins were incubated with thrombin
(1 unit/100 μg of protein) at room temperature for 14 h. The thrombin-treated samples
were then passed through a GS4B column. The GST and the un-cleaved GST-MsCFP9

10 were bound to the column, while the cleaved CFP-10 was collected in the flow
through fractions. The resulting cleaved CFP-10 is at least 90% pure.
2.2

PURIFICATION OF MSESAT-6/MSCFP-10 HETERODIMERS

The purified His-tagged MsESAT-6 proteins were incubated with 3 times in molar ratio
of the purified MsCFP-10 in the binding buffer (20 mM Tris-Cl, 100 mM NaCl, pH 7.3) at
room temperature for 2 hours. The mixture was loaded into a pre-equilibrated Ni2+column, on which the His-tagged protein complexes bound. The column was washed
three times with the binding buffer to wash off free MsCFP-10 proteins, and the bound
proteins were eluted with a linear gradient of the elution buffer (20 mM Tris-Cl, 100 mM
NaCl, 500 mM imidazole, pH 7.3). The eluted proteins were applied to gel filtration using
the Superdex 75 column, and the fractions of the heterodimer was then collected,
concentrated to at least 1 mg/ml and stored at -80 °C [22].
2.3

NATIVE GEL SHIFT ASSAY

1 μM of MsCFP-10 was incubated with MsESAT-6 at various concentrations (0.5, 1.5,
and 2 μM, respectively) at room temperature (RT) for 2 h. The samples were applied to
native gel electrophoresis, followed by Coomassie Brilliant Blue staining [22].
2.4

LIPOSOME PREPARATION

1, 2-dioleoyl-sn-glycero-3- phosphocholine (DOPC) (20 mg/ml in chloroform) was dried
under nitrogen gas to form a lipid film, followed by vacuum overnight to remove residual
solvent. The dry lipid film was rehydrated by six freeze-thaw cycles in 10 mM HEPES
(pH 7.4) and 150 mM KCl, and then extruded by passage through a 200-nm pore size
polycarbonate filter in a mini-extruder. The liposome solution was applied to a G-25
10

desalting column equilibrated with 10 mM HEPES (pH 7.4) and 150 mM NaCl for buffer
exchange [22, 23, 24].
2.5

K+ RELEASE ASSAY

200 μl of the K+-doped liposomes were added into 5 ml of 10 mM buffers at various pH
(sodium acetate (NaAc), pH 5.0; HEPES, pH 7.0) containing 150 mM NaCl. The purified
proteins were injected into the solution with continuous stirring (final concentration 3
μM). Release of K+ from liposomes was monitored using a K+-selective electrode (Orion
Research) connected to a microcomputer pH/mV/Temp meter 6171. The signal was
transmitted by a data transmitter (DATAQ) and displayed with DATAQ software [22, 23,
24].
2.6

EXPRESSION AND PURIFICATION MTBESAT-6, TRUNCATIONS P1, P2, AND P3

The gene of N-terminal amino acids 1-10 deletion (P1), C-terminal amino acids 85-95
deletion (P2) and both N- and C- terminal deletion (P3) were obtained by PCR (Fig.
2.1). Gene P1 and P3 were cloned on to the vector pGEX4T separately to produce
GST-tag proteins. Gene P2 was cloned onto vector pET22b to produce His-tag proteins.
Protein P1 and P3 were expressed and purified the same way as MsCFP-10 as
described above. And protein P2 was expressed and purified with the same way as
MtbESAT-6 protein as described above.
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Figure 2.1: P1: N-terminal amino acids 1~10 deletion. P2: C-terminal amino acids
85~95 deletion. P3: both N- and C- terminal deletion.
2.7

THE TIME-LAPSE INTENSITY MEASUREMENT OF ANTS/DPX DEQUENCHING

The liposomes containing the dye/quencher pair, 8-aminonapthalene-1, 3, 6-trisulfonic
acid (ANTS)/p-xylene-bispyridinium bromide (DPX), were prepared by the same way as
K+ release (described above, desalting buffer: 5 mM HEPES, 150 mM NaCl, pH 7.3).
Rehydrating solution: 50 mM ANTS, 50 mM DPX, 5 mM HEPES (pH 7.3).
The ANTS fluorescence dequenching was measured in an ISS-K2 multiphase
frequency and modulation fluorometer (excitation: 380 nm, emission: 520 nm). 100 μg
of purified P1, P2, P3 and WT MtbESAT-6 (Control) were separately diluted into regular
gel filtration buffer (20 mM Tris-Cl, 100 mM NaCl, pH 7.3 final volume 1.3 ml) that
contains 100 μl of the prepared liposomes and incubated at RT for 30 min. The solution
then was loaded into cuvette with continuous stirring. After the baseline was stabilized,
200 μl of low pH buffer (50 mM NaAc, 150 mM NaCl, pH 4.0) was injected into the
cuvette, and the fluorescence signal was monitored in real time. Crossed polarizers on
12

excitation and emission beams, and a 395-nm long-path filter were used to reduce the
background scatter (Fig. 2.2) [22].

Figure 2.2: ANTS/DPX fluorescent assay
2.8

ULTRAVIOLET CIRCULAR DICHROISM (CD)

20 μM of P1, P2 and P3 were prepared separately in 10 mM pH 5.0 and pH 7.0
NaH2PO4/Na2HPO4 buffer. Samples were scanned at wavelengths between 180 and
260 nm in a CD spectropolarimeter.
13

2.9

INTRINSIC TRYPTOPHAN FLUORESCENCE

10 μM of the purified proteins (P1, P2, P3 and WT MtbESAT-6 as control) were
incubated either in a neutral pH buffer (20 mM TrisHCl, 100 mM NaCl, pH 7.0) or an
acidic buffer (20 mM NaAc, 100 mM NaCl, pH 4.0) for 30 min. The intrinsic tryptophan
fluorescence was measured in the ISS-K2 fluorometer (excitation: 295 nm, emission:
310–450 nm). A 305 nm long-path filter was applied in the emission channel to reduce
the background. The emission spectra of the proteins were calibrated with the emission
spectra of the same pH buffers without proteins in VINCI software.
2.10

ANS FLUORESCENCE

5 μM of MtbESAT-6 or MsESAT-6 were incubated with 100 μM of 8-anilino-1naphthalenesulfonate (ANS) in either pH 7.0 or pH 5.0 buffers for 30 min at dark. The
ANS emission spectra of the samples were measured in the ISS-K2 fluorometer with
excitation at 380 nm and emission at 400–600 nm. A 395 nm long-path filter was placed
in the emission path to reduce the backgrounds. The emission spectra of the samples
were calibrated with the same buffers (pH 7.0 or pH 5.0) without proteins in VINCI
software (Fig. 2.3) [22].

14

Figure 2.3: ANS fluorescent assay
2.11

CYS SUBSTITUTION MUTANTS CONSTRCTION

4th, 10th, 34th, 37th, 45th, 55th, 60th, and 88th residues were chosen to produce Cys
substitution mutants. “Quickchange” mutation methods were used to obtain Cys
substitution MtbESAT-6 mutants. Protein purification protocol was the same as “ oncolumn” refolding as described above.
2.12

THE NBD FLUORESCENCE ASSAY

IANBD

[N,

N’-dimethyl-N-

(iodoacetyl)-N’-

(7-nitrobenz-2-oxa-1,

3-diazol)

ethylenediamine] was added at a 10-fold molar excess of the proteins in the presence of
10mM of reducing agent TCEP, and the mixture was incubated for over night at 4 °C (At
dark). Next day, the free dye was removed by size exclusion chromatography HiPrep
26/10 desalting column. Fractions of the NBD-labeled protein were pooled together and
stored

at

–80

°C.

The

labeling

efficiency

was

estimated

by

absorbance

spectrophotometry (ε478 = 25,000 M-1 cm-1 for NBD, and ε280 = 17990 M-1 cm-1 for
15

MtbESAT-6). The liposomes were prepared with regular gel filtration buffer (Fig. 2.4)
[22].
The NBD fluorescence was measured in an ISS-K2 multiphase frequency and
modulation fluorometer (excitation: 488 nm, emission: 544 nm). 200 μg of labeled
proteins Q4C, G10C, Q34C, T37C, G45C, Q55C, A60C, and G88C were separately
diluted into regular gel filtration buffer that contains 100 μl of the prepared liposomes.
Incubate at RT for 30 min at dark. The solution then was loaded into cuvette with
continuous stirring. After the base line was stabilized, 200 μl of low pH buffer (50 mM
NaAc, 150 mM NaCl, pH 4.0) was injected into the cuvette, and the fluorescence signal
was monitored in real-time. Crossed polarizers on excitation and emission beams, and
a 515 nm long-path filter were used to reduce the background scatter.

16

Figure 2.4: NBD fluorescent assay
2.13

PEGS PREPARITION AND ANTS/DPX DEQUENCHING ASSAY

PEG600, 1000, 2000, 2500, 3000, 4000, 6000, 8000 were prepared as 50mM stock
concentration then stock at -20 °C. The protocol followed the previously described
ANTS/DPX dequenching assay except one more step was added:

5 mM of PEGs

were added separately into the gel filtration butter that contains 100 μg of WT
MtbESAT-6 protein and 100 μl of liposomes and incubated for 30 min (Fig. 2.5).

17

Figure 2.5: ANTS/DPX fluorescent assay with PEGs
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CHAPTER 3: RESULTS
3.1

EXPRESSION AND PURIFICATION OF MSCFP-10 AND MSESAT-6

On-column refolding and purification protocol was used to minimize protein degradation
and increase the purification efficiency. The purified MsESAT-6 protein is soluble in
aqueous solution and migrates as a single band in SDS-PAGE with at least 90% purity.
MsCFP-10 was expressed soluble and was purified with GST tag protocol. After
thrombin treatment, the cleaved MtbCFP-10 was purified as a soluble protein with
above 90% purity (Fig. 3.1B).

19

Figure 3.1: A. Sequence alignment of MtbESAT-6 and MsESAT-6. B. Recombinant
proteins of MsESAT-6, MsCFP-10, and MsESAT-6/ CFP-10 heterodimer were purified
and examined by SDS-PAGE, followed by Coomassie staining. C. 3  M of the
indicated proteins were injected into the liposome solutions at pH 5.0. The release of K +
ions from the liposomes at 60 s of post-injection was measured and quantified from at
least three independent experiments. D. Native gel shift binding assay. MsESAT-6 and
MsCFP-10 were incubated at the indicated molar ratio at pH 7.0 and then applied to
native gel electrophoresis, followed by Coomassie Blue staining.
3.2

NATIVE GEL SHIFT BINDING ASSAY OF MSESAT-6/MSCFP-10 SHOWS 1:1 BINDING

The purified MsESAT-6 and MsCFP-10 bound to each other in a dose-dependent
manner, and formed a heterocomplex that migrated as a distinct band as indicated in
the native gel electrophoresis (Fig. 3.1D).
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3.3

COMPARED WITH MTBESAT-6, MSESAT-6 INDUCED LITTLE RELEASE OF K+ FROM THE

LIPOSOMES
MsESAT-6 shares high sequence homology with MtbESAT-6, including most of the
conserved hydrophobic residues (Fig. 3.1A). MtbESAT-6, MtbCFP-10, and the
MtbESAT-6/CFP-10 heterodimer were purified by a colleague. K+ release assay then
was carried out. At low pH, the level of K+ release induced by MsESAT-6 was
significantly lower than that induced by equal amount of MtbESAT-6. MsCFP-10 and the
MsESAT-6/CFP-10 heterodimer induced little release of K+ as their Mtb-counterparts
(Fig. 3.1C)
3.4

AT LOW PH, P1, P2 AND P3 INDUCED A WEAKER LEAKAGE OF THE MEMBRANE VESICLES

CONTAINING

ANTS/DPX THAN WILD TYPE MTBESAT-6

ANTS/DPX, the anion/cation fluorophore/quencher pair, is widely used for membrane
leakage measurement [25, 26]). ANTS fluorescence is quenched by DPX when they are
close together inside the liposomes, and it is dequenched upon release into the
solution. As expected, addition of WT MtbESAT-6 caused significant membrane lysis
and induced a sharp increase of ANTS fluorescence, while P1, P2 and P3 proteins
induced

much

lower

fluorescence
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dequenching,

especially

for

P3.
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Figure 3.2: At low pH, P1, P2 and P3 induced a weaker leakage of the membrane
vesicles containing ANTS/DPX than wild type MtbESAT-6. Liposomes containing the
dye/quencher pair, ANTS/DPX, and the proteins (100 μg per reaction) were diluted into
a pH 7.4 buffer with continuous stirring. Once the fluorescence base line was stabilized,
200 μl pH 4.0 buffer was injected into the solution. The dequenching of ANTS
fluorescence due to leakage of the membrane vesicles was recorded at emission 520
nm with excitation at 380 nm. The representative recordings of ANTS dequenching are
shown in A. The fluorescence intensity at 200 s of post-injection was quantified from
three independent measurements and shown in B.
3.5

P1, P2 AND P3 WERE FOLDED CORRECTLY AT PH 5.0 AND PH 7.0

Ultraviolet circular dichroism (CD) measures the secondary and tertiary structure of
proteins. Measurements can be made on proteins in the solution phase, and critically
time-resolved measurements can be made with millisecond resolution. This approach
has been widely used for investigating protein folding. Spectra for all proteins WT
MtbESAT-6, P1, P2 and P3 all showed stronger folding at low pH, especially for P1 and
P3 [27].
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Figure 3.3: Wavelengths from 190 nm to 300 nm were scanned and plotted in A. WT
MtbESAT-6; B. P1; C. P2; D. P3. The spectra in the far UV region between 180 and 260
nm, which reported secondary structure, suggested proteins folded correctly and even
tighter at pH 5.0 for all four proteins, especially on P1 and P3. Predicted secondary
structure percentages (http://k2d3.ogic.ca/): WT pH 7.0: α helix: 81.52%, β strand:
0.31%; WT pH 5.0: α helix: 94.1%, β strand: 0.26%; P1 pH 7.0: α helix: 68.16%, β
strand: 0.41%; P1 pH 5.0: α helix: 94.44%, β strand: 0.27%; P2 pH 7.0: α helix: 93.99%,
β strand: 0.27%; P2 pH 5.0: α helix: 94.58%, β strand: 0.3%; P3 pH 7.0: α helix:
68.08%, β strand: 0.39%; P3 pH 5.0: α helix: 93.62%, β strand: 0.27%.
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3.6

AT

LOW PH, MEMBRANE INTERACTIONS OF WILD TYPE,

P1, P2,

ASSOCIATED WITH A REDUCED SOLVENT-EXPOSED HYDROPHOBICITY.
EXHIBITED WEAKER

AND

P1, P2

P3

WERE

AND

P3

ANS FLUORESCENCE UPON ACIDIFICATION.

To further confirm that the pH-dependent membrane interaction is due to an increased
solvent-exposed

hydrophobicity,

an

extrinsic

fluorescence

dye,

8-anilino-1-

naphthalenesulfonate (ANS), was used to measure change of hydrophobic residues
after acidification. ANS was incubated with the proteins either at pH 5.0 or pH 7.0 (Fig.
3.4). ANS is hardly fluorescent in aqueous environment, but becomes highly fluorescent
when it binds to hydrophobic sites of proteins. As expected, P1, P2 and P3 showed little
ANS fluorescence at both pH 7.0 and pH 5.0, comparing with MtbESAT-6, suggesting
that P1, P2 and P3 have less solvent-exposed hydrophobic residues at neutral pH, and
its conformation is less responsive to acidification, especially for P3.
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Figure 3.4 At low pH, membrane interactions of wild type, P1, P2 and P3 were
associated with a reduced solvent-exposed hydrophobicity. P1, P2 and P3 exhibited
weaker ANS fluorescence upon acidification. 5 μm MtbESAT-6 WT, P1, P2 or P3 were
incubated with 100 μm of ANS at either pH 7.0 or pH 5.0 buffers for 30 min. The
samples were excited at 380 nm and the emission fluorescence intensity of ANS was
recorded at 400–600 nm. The emission spectra of the samples were calibrated with the
same buffers (pH 7.0 or pH 5.0) without proteins. The representative results are shown
in A. The difference of peak emission intensity at 468 nm (pH 5.0 and pH 7.0) was
quantified from at least three independent experiments and shown in B.
3.7

ACIDIFICATION TRIGGERED A STRONGER CONFORMATIONAL CHANGE ON P1, P2 AND P3

THAN WT MTBESAT-6.

Transition of an aqueous-soluble protein into a membrane-interacting protein is always
accompanied by significant conformational changes. Therefore, we measured the
intrinsic Trp fluorescence of the proteins to test the acidification-dependent
conformational changes (Fig. 3.5). The emission spectra of WT MtbESAT-6 showed
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that there was a left shift of the peak maximum from pH 7.0 to pH 5.0 (Fig. 3.5A),
suggesting a significant conformational change occurred upon acidification. In contrast,
P1, P2 and P3 showed significant higher shift in the emission spectra between pH 7.0
and pH 5.0 (Fig. 3.5 B,C and D). These data are consistent with the results obtained
from the ANTS/DPX dequenching assay (Fig. 3.2), and CD (Fig. 3.3). It demonstrated
that acidification induced a stronger conformational change on P1, P2 and P3 compare
with WT MtbESAT-6 [22].
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Figure 3.5 Acidification triggered a stronger conformational change on P1, P2 and P3
than WT MtbESAT-6. 10 μM of MtbESAT-6 WT (A), P1 (B), P2 (C) or P3 (D) were
incubated either at pH 7.0 or at pH 5.0 for 30 min. The samples were excited at 295 nm
and the emission spectra of Trp fluorescence of the samples were recorded at 310–450
nm. The emission spectra of the samples were calibrated with the emission spectra of
the same buffers (pH 7.0 or pH 5.0) without proteins. The representative data from at
least three independent experiments are shown in the figure.

27

3.8

NBD-LABELED G45C AND G60C SHOWED STRONG FLUORESCENCE SIGNAL AT LOW PH,

INDICATING THAT THESE TWO AMINO ACIDS WERE UNDER HYDROPHOBIC ENVIRONMENT AFTER
CONFORMATIONAL CHANGE INDUCED BY ACIDIFICATION.

To demonstrate the insertion of WT MtbESAT-6 into liposomal membranes directly, we
attached an environment-sensitive dye (NBD) to introduced Cys at position of Q4C,
G10C, Q34C, T37C, G45C, Q55C, A60C, and G88C and monitored their fluorescence
emission intensity during membrane disruption. The intensity of NBD fluorescence at
544 nm increased upon a shift from a polar to a non-polar environment and this
increase was observed from G45C and A60C (Fig.3.6) [28].
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Figure 3.6 G45C and A60C showed strong fluorescence signal at low pH, indicating
that those two amino acids were under hydrophobic environment after conformational
change induced by acidification.
3.9

PEGS FACILITATED MTBESAT-6 MEMBRANE ACTIVITY.

It has been reported that PEGs were used to measure the size of pores on the
membranes. Our previous results strongly suggested that MtbESAT-6 disrupted
membrane vesicles by pore formation [29]. In this study, we chose a set of PEGs with
molecular weights ranging from 600 to 10000 to measure the size of MtbESAT-6 pore,
assuming that only the PEG with a similar size to the pore will partition into the ESAT-6
pore and block it (Fig. 3.7). Instead of blocking the pore, however, the result showed
that PEGs significantly increased the signals of fluorescence dequenching in a size- and
concentration-dependent manner. The higher molecular weight and concentration of
PEGs, the better fluorescence dequenching. It suggests that PEGs assist MtbESAT-6
membrane activity with an unknown mechanism.
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Figure 3.7 PEGs facilitated MtbESAT-6 membrane activity. Higher molecular weight
and concentration of PEGs showed higher fluorescence signal, suggested that the
ability of PEGs to assist MtbESAT-6 membrane activity depends on the molecular
weight and concentration. The protocol followed the previously described ANTS/DPX
dequenching assay except one more step was added: 5 mM of PEGs were added
separately into the gel filtration butter that contains 100 μg of WT MtbESAT-6 protein
and 100 μl of liposomes and incubated for 30 min. A. Concentration titration of
PEG8000. B. Membrane interacting-activity facilitation by different PEGs.
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CHAPTER 4: DISCUSSION
My collaboration with Joaquin De Leon identified a differential membrane interaction
between MtbESAT-6 and MsESAT-6. It was confirmed that the biological functions
MtbESAT-6 involved in the virulence of Mtb, which is not present in MsESAT-6. Based
on this significant finding, my study further investigated the mechanism underlying the
MtbESAT-6-induced virulence [22].
Using an on-column refolding approach, we purified a sufficient amount of ESAT-6
protein. This approach has proved efficient for purifying insoluble proteins. However it is
not efficient for N- terminal truncations and mutants of ESAT-6 due to complications in
expression in E. coli inclusion bodies. The alternative approach was to generate soluble
ESAT-6 by GST tagging. This approach has been used with success for most of our
proteins containing N-terminal truncations or mutations [30, 31].
It has been reported that C-terminus of ESAT-6 is responsible for the membrane
interaction [32]. We wanted to understand the roles of N- and C- termini of ESAT-6 in
membrane disruption. ANTS/DPX assay verified the importance of both N- and Cterminal flexible tails on membrane interaction activity. Deletion of either of the N- or Cterminal flexible tails resulted in a significant decrease in membrane disruption. Other
experiments, such as ANS fluorescence and CD analysis, supported this result through
other aspects [32, 33]. Also, relative to the rapid rate of membrane disruption caused by
Triton X-100, the membrane leakage caused by MtbESAT-6 was a slower process,
which suggested MtbESAT-6 formed pores on the membranes, instead of completely
lysing the membranes. This phenomenon was also shown in our previous K+ release
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assay [22]. Hence, we hypothesized that MtbESAT-6 caused membrane disruption by
forming discrete pores on the membranes.
Combining the results from the specific aims 1 and 2, we developed a membrane
insertion model of MtbESAT-6 (Fig. 4.1). According to NBD fluorescent assay, the
labeling of residue Q4 showed high fluorescent even at pH 7.0 (under hydrophobic
environment), suggesting that the N- terminus might be anchored onto the cell
membrane before the conformational change at pH 5.0. The residues G45 and A60
showed high NBD fluorescent at pH 5.0, but not pH 7.0, suggesting that the two
residues inserted into the membranes after the pH-dependent conformational change.
Therefore, the hypothetical model is that N- and C- terminal flexible tails are responsible
for the binding at cell surface in pH 7.0, and once the pH dropped, the two α-helixes
flipped and inserted into the membranes.
ANTS/DPX fluorescent assay with PEGs was meant to measure the pore size of
MtbESAT-6 based on the reported studies. Surprisingly, the PEGs showed that they
facilitated pore formation of MtbESAT-6 in a dose- and molecular weight-dependent
manner. A similar phenomenon was reported and inferred for the PEGs, which was due
to the hydrophobic environment formed on the surface of the membrane by larger PEG
molecules [34]. Future study should be focused to verify how PEGs facilitate membrane
disruptions.
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4.1

FUTURE DIRECTION

The further study will focus on the specific residues of both N- and C- termini of
MtbESAT-6 and will identify membrane-inserting residues and their roles in membrane
disruption. More hydrophobic residues should be tested in order to confirm the
membrane insertion model.
Our results suggested that MtbESAT-6 disrupted the membrane by pore formation>
Thus, determination of the pore size as well as the oligomeric state of ESAT-6 pore on
the membrane will be a part of our work future work.
MtbESAT-6/CFP-10 might interact with other proteins during the infection, such as
ClpP1 and ClpP2 [35, 36]. The truncated mutants generated in this study can be applied
to the study of other binding partners of ESAT-6.
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Figure 4.1: MtbESAT-6 membrane insertion model.
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